Malignant Bile Duct Neoplasm — Trials

Malignant Bile Duct Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

883 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 223
Recruiting: 126
Ph III recruiting: 7
Growth YoY: +14.6%
Industry share: 16%
Top sponsor: National Cancer Institute (NCI)
Termination share: 34.7%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (119)

clinicaltrialsPublishedShowing 51–65 of 65 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT01073839	Adjuvant Cisplatin Plus Gemcitabine in Operable Cholangiocellular Carcinoma.	completed	Phase 1 / Phase 2	33	University of ZurichOTHER	1	Sep 18, 2015	clinicaltrials
NCT00544193	Gemcitabine and Radiation Therapy in Treating Patients With Locally Advanced Upper Gastrointestinal Cancer	completed	Phase 1	16	City of Hope Medical CenterOTHER	0	Jun 8, 2015	clinicaltrials